Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis

[1]  M. Pittenger,et al.  Mesenchymal stem cell perspective: cell biology to clinical progress , 2019, npj Regenerative Medicine.

[2]  A. Serrano-Mollar Cell Therapy in Idiopathic Pulmonary Fibrosis† , 2018, Medical sciences.

[3]  Qi Zhou,et al.  SIRT6 deficiency results in developmental retardation in cynomolgus monkeys , 2018, Nature.

[4]  Guoji Guo,et al.  Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing , 2018, Genome Biology.

[5]  Xiaolong Wei,et al.  Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats , 2018, International journal of molecular medicine.

[6]  L. Richeldi,et al.  Idiopathic pulmonary fibrosis: pathogenesis and management , 2018, Respiratory Research.

[7]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[8]  D. S. Kim,et al.  Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis , 2018, Respiratory Research.

[9]  Huanping Zhou,et al.  [Research progress of mesenchymal stem cells in the treatment of ALI]. , 2017, Zhonghua wei zhong bing ji jiu yi xue.

[10]  Liu Wang,et al.  Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations , 2017, Stem cell reports.

[11]  J. Hare,et al.  Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials , 2017, Circulation research.

[12]  Vasilis Ntziachristos,et al.  Fluorescence molecular tomography of DiR-labeled mesenchymal stem cell implants for osteochondral defect repair in rabbit knees , 2017, European Radiology.

[13]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[14]  P. Thompson,et al.  Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. , 2015, Journal of visualized experiments : JoVE.

[15]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[16]  Charles F. Burant,et al.  Impact of Anesthesia and Euthanasia on Metabolomics of Mammalian Tissues: Studies in a C57BL/6J Mouse Model , 2015, PloS one.

[17]  A. Azuma,et al.  A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .

[18]  B. Thompson,et al.  Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. , 2015, The Lancet. Respiratory medicine.

[19]  M. Matthay,et al.  Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. , 2014, The Lancet. Respiratory medicine.

[20]  Z. Jia,et al.  Cell-based therapy in lung regenerative medicine , 2014, Regenerative Medicine Research.

[21]  L. Ortiz,et al.  Cell therapy trials for lung diseases: progress and cautions. , 2013, American journal of respiratory and critical care medicine.

[22]  Q. Hao,et al.  Adult stem cells for acute lung injury: Remaining questions and concerns , 2013, Respirology.

[23]  Yufang Shi,et al.  How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.

[24]  J. Kurtzberg,et al.  Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[26]  R. Stewart,et al.  A mesoderm-derived precursor for mesenchymal stem and endothelial cells. , 2010, Cell stem cell.

[27]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[28]  E. J. Lee,et al.  Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. , 2010, Tissue engineering. Part A.

[29]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[30]  Nathaniel S. Hwang,et al.  In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells , 2008, Proceedings of the National Academy of Sciences.

[31]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[32]  L. Ortiz,et al.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.

[33]  M. Salto‐Tellez,et al.  Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs , 2007, Stem cells.

[34]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[35]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  N. Socci,et al.  Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells , 2005, PLoS medicine.

[37]  J. Chiche,et al.  Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. , 2003, Critical care medicine.

[38]  H. T. Moriya,et al.  Nonlinearity of respiratory mechanics during bronchoconstriction in mice with airway inflammation. , 2002, Journal of applied physiology.

[39]  P. Suter,et al.  Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. , 2002, American journal of respiratory and critical care medicine.

[40]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[41]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[42]  G. Laurent,et al.  The acute respiratory distress syndrome: fibrosis in the fast lane , 1998, Thorax.

[43]  J. Iredale,et al.  Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. , 1996, Gastroenterology.

[44]  D. Schuppan,et al.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. , 1994, The American journal of pathology.